44 related articles for article (PubMed ID: 3083782)
1. Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice.
Shindo H; Ogura T; Masuno T; Hayashi S; Kishimoto S
Cancer Immunol Immunother; 1985; 20(2):145-50. PubMed ID: 3930067
[TBL] [Abstract][Full Text] [Related]
2. In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.
Ogura T; Shindo H; Shinzato O; Namba M; Masuno T; Inoue T; Kishimoto S; Yamamura Y
Cancer Immunol Immunother; 1982; 13(2):112-7. PubMed ID: 6819079
[TBL] [Abstract][Full Text] [Related]
3. Analysis of therapeutic effect in experimental chemoimmunotherapy for rat ascites tumor.
Ogura T; Shinzato O; Sakatani M; Shindo H; Namba M; Kishimoto S; Yamamura Y
Cancer Immunol Immunother; 1982; 14(2):67-72. PubMed ID: 6821517
[TBL] [Abstract][Full Text] [Related]
4. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.
Kato I; Yokokura T; Mutai M
Cancer Immunol Immunother; 1988; 26(3):215-21. PubMed ID: 3133111
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumoricidal macrophages from bone marrow cells of normal mice or mice bearing a colony-stimulating-factor-producing tumor.
Hosoe S; Ogura T; Hayashi S; Komuta K; Ikeda T; Shirasaka T; Kawase I; Masuno T; Kishimoto S
Cancer Immunol Immunother; 1989; 28(2):116-22. PubMed ID: 2645051
[TBL] [Abstract][Full Text] [Related]
6. Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.
Masuno T; Hayashi S; Ito M; Ikeda T; Ogura T; Kishimoto S; Yamamura Y
Cancer Immunol Immunother; 1986; 22(2):132-8. PubMed ID: 3521853
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of the generation of cell-mediated cytotoxicity in culture by mitomycin C.
Akiyoshi T; Arinaga S; Tsuji H
Cancer Immunol Immunother; 1987; 24(3):259-62. PubMed ID: 3109736
[TBL] [Abstract][Full Text] [Related]
8. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.
Dullens HF; Vuist W; Van der Maas M; Den Otter W
Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093
[TBL] [Abstract][Full Text] [Related]
9. Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts.
Gallily R; Gifford GE; Loewenstein J
Cancer Immunol Immunother; 1986; 23(1):60-6. PubMed ID: 3490307
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulating activity of tumor-associated macrophages.
Dougherty GJ; McBride WH
Cancer Immunol Immunother; 1986; 23(1):67-72. PubMed ID: 3464353
[TBL] [Abstract][Full Text] [Related]
11. Suppression of MHV3 virus-activated macrophages by dieldrin.
Krzystyniak K; Bernier J; Hugo P; Fournier M
Biochem Pharmacol; 1986 Aug; 35(15):2577-86. PubMed ID: 3017357
[TBL] [Abstract][Full Text] [Related]
12. Enhanced susceptibility of target KMT-17 cells to activated macrophages by treatment with the antitumor agent bleomycin.
Xu ZY; Hosokawa M; Morikawa K; Kobayashi H
Cancer Immunol Immunother; 1986; 23(1):46-50. PubMed ID: 2429768
[TBL] [Abstract][Full Text] [Related]
13. Selective in vitro and in vivo growth inhibition against human yolk sac tumor cell lines by purified antibody against human alpha-fetoprotein conjugated with mitomycin C via human serum albumin.
Ohkawa K; Tsukada Y; Hibi N; Umemoto N; Hara T
Cancer Immunol Immunother; 1986; 23(2):81-6. PubMed ID: 2430705
[TBL] [Abstract][Full Text] [Related]
14. Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor.
Bocian RC; Dray S; Ben-Efraim S; Mokyr MB
Cancer Immunol Immunother; 1985; 20(1):61-8. PubMed ID: 3933817
[TBL] [Abstract][Full Text] [Related]
15. Activation of macrophages by ether analogues of lysophospholipids.
Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA
Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051
[TBL] [Abstract][Full Text] [Related]
16. Rat macrophage activation after treatment with the bleomycin group of antitumour antibiotics in vivo.
Micallef M; Hosokawa M; Togashi Y; Kobayashi H
Cancer Immunol Immunother; 1992; 35(2):106-12. PubMed ID: 1375871
[TBL] [Abstract][Full Text] [Related]
17. The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages.
Marcovitch S; Keisari Y
Cancer Immunol Immunother; 1985; 20(3):205-8. PubMed ID: 3851700
[TBL] [Abstract][Full Text] [Related]
18. Activation of mouse peritoneal macrophages by synthetic glyceroglycolipid liposomes.
Naito M; Kudo I; Mukai-Sato Y; Tsushima S; Nomura H; Nojima S; Inoue K
Cancer Immunol Immunother; 1987; 24(2):158-64. PubMed ID: 3829050
[TBL] [Abstract][Full Text] [Related]
19. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
